Garth Cumberlidge, PhDPresident & CEO
Chairman of Eyevensys SAS and former CEO of Mimetogen Pharmaceuticals. Successful track record of ophthalmology drug development, fund-raising and licensing.
John Clement, Ph.DExec. VP Business Development
A seasoned biotech executive, having held senior management positions in both R&D and business development with Ciba-Geigy, QLT and iCo.
Przemyslaw(Mike) Sapieha, Ph.DFounder & Chief Scientific Officer
Director of the Neurovascular Eye Disease Lab at Maisonneuve-Rosemont Hospital Research Centre and Wolfe Professor of translational vision research, Canada Research Chair in retina...